Rezolute Medical Affairs
@rzltmedaffairs.bsky.social
As representatives of a rare disease biotech company, we’re committed to connecting with healthcare professionals and advocates to foster transparent, meaningful conversations in the rare disease space.
We look forward to:
• Sharing updates on therapy innovations
• Providing educational resources
• Fostering meaningful connections within the HI community
Scan the QR code below to subscribe to our program & monthly e-newsletter, 𝘛𝘩𝘦 𝘙𝘦𝘻𝘰𝘭𝘶𝘵𝘪𝘰𝘯 𝘙𝘦𝘱𝘰𝘳𝘵
Click here to learn more: bit.ly/4iadvda
#MedSky
• Sharing updates on therapy innovations
• Providing educational resources
• Fostering meaningful connections within the HI community
Scan the QR code below to subscribe to our program & monthly e-newsletter, 𝘛𝘩𝘦 𝘙𝘦𝘻𝘰𝘭𝘶𝘵𝘪𝘰𝘯 𝘙𝘦𝘱𝘰𝘳𝘵
Click here to learn more: bit.ly/4iadvda
#MedSky
December 5, 2025 at 10:12 AM
We look forward to:
• Sharing updates on therapy innovations
• Providing educational resources
• Fostering meaningful connections within the HI community
Scan the QR code below to subscribe to our program & monthly e-newsletter, 𝘛𝘩𝘦 𝘙𝘦𝘻𝘰𝘭𝘶𝘵𝘪𝘰𝘯 𝘙𝘦𝘱𝘰𝘳𝘵
Click here to learn more: bit.ly/4iadvda
#MedSky
• Sharing updates on therapy innovations
• Providing educational resources
• Fostering meaningful connections within the HI community
Scan the QR code below to subscribe to our program & monthly e-newsletter, 𝘛𝘩𝘦 𝘙𝘦𝘻𝘰𝘭𝘶𝘵𝘪𝘰𝘯 𝘙𝘦𝘱𝘰𝘳𝘵
Click here to learn more: bit.ly/4iadvda
#MedSky
As patients navigate life with #hyperinsulinism, #Rezolute Patient Affairs team is committed to walking alongside them every step of the way. That’s why we are excited to launch 𝘛𝘩𝘦 𝘙𝘦𝘻𝘰𝘭𝘶𝘵𝘪𝘰𝘯, a new initiative dedicated to supporting those impacted by hypoglycemia related to hyperinsulinism
December 5, 2025 at 10:10 AM
As patients navigate life with #hyperinsulinism, #Rezolute Patient Affairs team is committed to walking alongside them every step of the way. That’s why we are excited to launch 𝘛𝘩𝘦 𝘙𝘦𝘻𝘰𝘭𝘶𝘵𝘪𝘰𝘯, a new initiative dedicated to supporting those impacted by hypoglycemia related to hyperinsulinism
We were honored to attend the UKI NETS Annual Conference yesterday and connect with leading experts and people impacted by #insulinomas, a rare type of neuroendocrine tumor.
At Rezolute, we’re committed to advancing care options for the #hyperinsulinism
#MedSky #EndoSky #OncSky #raredisease
At Rezolute, we’re committed to advancing care options for the #hyperinsulinism
#MedSky #EndoSky #OncSky #raredisease
December 5, 2025 at 10:05 AM
We were honored to attend the UKI NETS Annual Conference yesterday and connect with leading experts and people impacted by #insulinomas, a rare type of neuroendocrine tumor.
At Rezolute, we’re committed to advancing care options for the #hyperinsulinism
#MedSky #EndoSky #OncSky #raredisease
At Rezolute, we’re committed to advancing care options for the #hyperinsulinism
#MedSky #EndoSky #OncSky #raredisease
November is #NationalFamilyCaregiversMonth, a time to honor and celebrate the incredible #caregivers who provide invaluable support to the #hyperinsulinism community.
Hear more from caregivers here: bit.ly/46IK51G
#Rezolute #congenitalHI #tumorhyperinsulinism #raredisease #MedSky #EndoSky #PedSky
Hear more from caregivers here: bit.ly/46IK51G
#Rezolute #congenitalHI #tumorhyperinsulinism #raredisease #MedSky #EndoSky #PedSky
November 26, 2025 at 8:42 PM
November is #NationalFamilyCaregiversMonth, a time to honor and celebrate the incredible #caregivers who provide invaluable support to the #hyperinsulinism community.
Hear more from caregivers here: bit.ly/46IK51G
#Rezolute #congenitalHI #tumorhyperinsulinism #raredisease #MedSky #EndoSky #PedSky
Hear more from caregivers here: bit.ly/46IK51G
#Rezolute #congenitalHI #tumorhyperinsulinism #raredisease #MedSky #EndoSky #PedSky
Today is #WorldPancreaticCancerDay, and we're shining a light on #insulinomas - a rare type of tumor that usually forms from the insulin-secreting cells in the pancreas, resulting in hypoglycemia.
Explore how #Rezolute is working to shape the future of #hyperinsulinism: bit.ly/46IK51G
#MedSky
Explore how #Rezolute is working to shape the future of #hyperinsulinism: bit.ly/46IK51G
#MedSky
November 20, 2025 at 10:51 PM
Today is #WorldPancreaticCancerDay, and we're shining a light on #insulinomas - a rare type of tumor that usually forms from the insulin-secreting cells in the pancreas, resulting in hypoglycemia.
Explore how #Rezolute is working to shape the future of #hyperinsulinism: bit.ly/46IK51G
#MedSky
Explore how #Rezolute is working to shape the future of #hyperinsulinism: bit.ly/46IK51G
#MedSky
#Rezolute was proud to be a Diamond Sponsor of Congenital Hyperinsulinism International’s Sugar Soirée on Saturday, an annual fundraiser that supports families impacted by #congenitalHI and raises awareness.
Learn more about our Phase 3 trial in congenital HI here: bit.ly/47K5Oa3
#EndoSky #PedSky
Learn more about our Phase 3 trial in congenital HI here: bit.ly/47K5Oa3
#EndoSky #PedSky
November 17, 2025 at 10:40 PM
#Rezolute was proud to be a Diamond Sponsor of Congenital Hyperinsulinism International’s Sugar Soirée on Saturday, an annual fundraiser that supports families impacted by #congenitalHI and raises awareness.
Learn more about our Phase 3 trial in congenital HI here: bit.ly/47K5Oa3
#EndoSky #PedSky
Learn more about our Phase 3 trial in congenital HI here: bit.ly/47K5Oa3
#EndoSky #PedSky
#Rezolute is proud to support Neuroendocrine Cancer Awareness Day! Neuroendocrine tumors (NETs) can have a profound impact on patients’ lives, so join us in raising awareness and supporting those affected by NET cancers.
#LetsTalkAboutNETs #NETCancerDay #tumorhyperinsulinism #OncSky #EndoSky #MedSky
#LetsTalkAboutNETs #NETCancerDay #tumorhyperinsulinism #OncSky #EndoSky #MedSky
November 10, 2025 at 10:39 PM
#Rezolute is proud to support Neuroendocrine Cancer Awareness Day! Neuroendocrine tumors (NETs) can have a profound impact on patients’ lives, so join us in raising awareness and supporting those affected by NET cancers.
#LetsTalkAboutNETs #NETCancerDay #tumorhyperinsulinism #OncSky #EndoSky #MedSky
#LetsTalkAboutNETs #NETCancerDay #tumorhyperinsulinism #OncSky #EndoSky #MedSky
To learn more about our sunRIZE Phase 3 preliminary demographic and baseline clinical characteristics, please check out our poster on our website: rezolutebio.com/wp-content/u... #SPES2025
#RZLT #CongenitalHI #raredisease #hyperinsulinism #ersodetug #PedSky #EndoSky #MedSky
#RZLT #CongenitalHI #raredisease #hyperinsulinism #ersodetug #PedSky #EndoSky #MedSky
October 14, 2025 at 9:47 PM
To learn more about our sunRIZE Phase 3 preliminary demographic and baseline clinical characteristics, please check out our poster on our website: rezolutebio.com/wp-content/u... #SPES2025
#RZLT #CongenitalHI #raredisease #hyperinsulinism #ersodetug #PedSky #EndoSky #MedSky
#RZLT #CongenitalHI #raredisease #hyperinsulinism #ersodetug #PedSky #EndoSky #MedSky
Our team was proud to attend the Southern Ped Endo Society Annual Meeting at UAB in Birmingham this past weekend, presenting an encore poster presentation of the preliminary demographic and baseline clinical characteristics from our Phase 3 #sunRIZE trial. #RZLT #SPES2025 #RZLTInAction #CongenitalHI
October 14, 2025 at 9:45 PM
Our team was proud to attend the Southern Ped Endo Society Annual Meeting at UAB in Birmingham this past weekend, presenting an encore poster presentation of the preliminary demographic and baseline clinical characteristics from our Phase 3 #sunRIZE trial. #RZLT #SPES2025 #RZLTInAction #CongenitalHI
Stay connected through The Rezolution—our new initiative for patients & caregivers featuring updates on therapies, advocacy, events & resources. Visit #RZLT For Patients page to learn more, meet our team & sign up for The Rezolution Report-our monthly newsletter bit.ly/46IK51G #congenitalHI #EndoSky
October 7, 2025 at 11:28 PM
Stay connected through The Rezolution—our new initiative for patients & caregivers featuring updates on therapies, advocacy, events & resources. Visit #RZLT For Patients page to learn more, meet our team & sign up for The Rezolution Report-our monthly newsletter bit.ly/46IK51G #congenitalHI #EndoSky
💙 #Rezolute was honored to support the #CHI Family Conference at @childrensphila.bsky.social this past weekend! Grateful to CHI, the physicians, and—most importantly—the patients & families who connected with the team and shared their #congenitalhyperinsulinism stories.
#PedSky #RZLTInAction
#PedSky #RZLTInAction
October 7, 2025 at 11:26 PM
💙 #Rezolute was honored to support the #CHI Family Conference at @childrensphila.bsky.social this past weekend! Grateful to CHI, the physicians, and—most importantly—the patients & families who connected with the team and shared their #congenitalhyperinsulinism stories.
#PedSky #RZLTInAction
#PedSky #RZLTInAction
What a weekend for #Rezolute Medical Affairs! 🌍 Our team proudly represented at #ASPED2025 (Dubai), #SCOPE (Long Beach), and #AAP2025 (Denver)—sharing insights on congenital hyperinsulinism and ersodetug (RZ358). Grateful to all who engaged with us! #RZLT #ersodetug #EndoSky #RZLTMedAffairsInAction
September 30, 2025 at 10:18 PM
What a weekend for #Rezolute Medical Affairs! 🌍 Our team proudly represented at #ASPED2025 (Dubai), #SCOPE (Long Beach), and #AAP2025 (Denver)—sharing insights on congenital hyperinsulinism and ersodetug (RZ358). Grateful to all who engaged with us! #RZLT #ersodetug #EndoSky #RZLTMedAffairsInAction
Reposted by Rezolute Medical Affairs
Excited to be at ASPED 2025 in Dubai to increase awareness of #Hyperinsulinism
September 26, 2025 at 6:15 AM
Excited to be at ASPED 2025 in Dubai to increase awareness of #Hyperinsulinism
This is an incredible outcome, representative of the Agency's recognition of ersodetug as a potential universal treatment for multiple forms of HI, and the high unmet need in this patient population. #EndoSky #MedSky #OncSky #RareDisease #Hyperinsulinism #TumorHI
Today we announced alignment with FDA on a streamlined design for the ongoing Phase 3 trial of ersodetug in patients with tumor hyperinsulinism (HI). Learn more: bit.ly/4mM7qVV
#MedSky #EndoSky #OncSky #TumorHI #Hyperinsulinism #RareDisease #DrugDevelopment
#MedSky #EndoSky #OncSky #TumorHI #Hyperinsulinism #RareDisease #DrugDevelopment
September 2, 2025 at 4:56 PM
This is an incredible outcome, representative of the Agency's recognition of ersodetug as a potential universal treatment for multiple forms of HI, and the high unmet need in this patient population. #EndoSky #MedSky #OncSky #RareDisease #Hyperinsulinism #TumorHI
Today we announced alignment with FDA on a streamlined design for the ongoing Phase 3 trial of ersodetug in patients with tumor hyperinsulinism (HI). Learn more: bit.ly/4mM7qVV
#MedSky #EndoSky #OncSky #TumorHI #Hyperinsulinism #RareDisease #DrugDevelopment
#MedSky #EndoSky #OncSky #TumorHI #Hyperinsulinism #RareDisease #DrugDevelopment
September 2, 2025 at 4:55 PM
Today we announced alignment with FDA on a streamlined design for the ongoing Phase 3 trial of ersodetug in patients with tumor hyperinsulinism (HI). Learn more: bit.ly/4mM7qVV
#MedSky #EndoSky #OncSky #TumorHI #Hyperinsulinism #RareDisease #DrugDevelopment
#MedSky #EndoSky #OncSky #TumorHI #Hyperinsulinism #RareDisease #DrugDevelopment
Proud to take part in this past weekend's 16th Annual Kongenitaler Hyperinsulinismus, e.V. meeting in Berlin, Germany. The Association continues to empower families facing #congenitalHI with education and support across every stage of life. #RareDisease #Hyperinsulinism #MedSky #EndoSky #PedSky
August 25, 2025 at 7:19 PM
Proud to take part in this past weekend's 16th Annual Kongenitaler Hyperinsulinismus, e.V. meeting in Berlin, Germany. The Association continues to empower families facing #congenitalHI with education and support across every stage of life. #RareDisease #Hyperinsulinism #MedSky #EndoSky #PedSky
We applaud Congenital Hyperinsulinism International, the authors, and—most importantly—the patients and families—for their groundbreaking, innovative study on the real-world experience of diazoxide in congenital hyperinsulinism. #MedSky #EndoSky #PedSky #CongenitalHI #Hyperinsulinism
August 23, 2025 at 12:10 AM
We applaud Congenital Hyperinsulinism International, the authors, and—most importantly—the patients and families—for their groundbreaking, innovative study on the real-world experience of diazoxide in congenital hyperinsulinism. #MedSky #EndoSky #PedSky #CongenitalHI #Hyperinsulinism
It was a privilege to connect with patients, caregivers, clinicians, and researchers who are united in advancing care for those affected by #cHI. We appreciate the ongoing collaboration and making a lasting impact for all those living with #hyperinsulinism!
#CongenitalHI #MedSky #EndoSky #RZLT
#CongenitalHI #MedSky #EndoSky #RZLT
🌍💙 Grateful to Connect at the UK Congenital HI Family Conference
A heartfelt thank you to the organizers and families who made this past weekend’s @chcharityuk.bsky.social #Hyperinsulinism Charity Family Conference in the UK such an inspiring and meaningful experience.
A heartfelt thank you to the organizers and families who made this past weekend’s @chcharityuk.bsky.social #Hyperinsulinism Charity Family Conference in the UK such an inspiring and meaningful experience.
July 31, 2025 at 5:28 PM
It was a privilege to connect with patients, caregivers, clinicians, and researchers who are united in advancing care for those affected by #cHI. We appreciate the ongoing collaboration and making a lasting impact for all those living with #hyperinsulinism!
#CongenitalHI #MedSky #EndoSky #RZLT
#CongenitalHI #MedSky #EndoSky #RZLT
🌍💙 Grateful to Connect at the UK Congenital HI Family Conference
A heartfelt thank you to the organizers and families who made this past weekend’s @chcharityuk.bsky.social #Hyperinsulinism Charity Family Conference in the UK such an inspiring and meaningful experience.
A heartfelt thank you to the organizers and families who made this past weekend’s @chcharityuk.bsky.social #Hyperinsulinism Charity Family Conference in the UK such an inspiring and meaningful experience.
July 31, 2025 at 5:25 PM
🌍💙 Grateful to Connect at the UK Congenital HI Family Conference
A heartfelt thank you to the organizers and families who made this past weekend’s @chcharityuk.bsky.social #Hyperinsulinism Charity Family Conference in the UK such an inspiring and meaningful experience.
A heartfelt thank you to the organizers and families who made this past weekend’s @chcharityuk.bsky.social #Hyperinsulinism Charity Family Conference in the UK such an inspiring and meaningful experience.
Reposted by Rezolute Medical Affairs
Meeting Sarah Dearman at the Children’s Hyperinsulinism Charity conference and learning about the charity’s work was inspiring. It was great to connect face to face with Davelyn Hood from Rezolute. Ersodetug offers real hope for better care, and I am excited about future collaboration #insulinoma
July 30, 2025 at 8:10 PM
Meeting Sarah Dearman at the Children’s Hyperinsulinism Charity conference and learning about the charity’s work was inspiring. It was great to connect face to face with Davelyn Hood from Rezolute. Ersodetug offers real hope for better care, and I am excited about future collaboration #insulinoma
📈ICYMI we presented Preliminary Patient Demographics And Baseline Characteristics from Phase 3 Study #sunRIZE of Ersodetug for Hypoglycemia due to #CongenitalHI at #ENDO2025
📎 View the full poster here: bit.ly/416Pdt5
🙏Thank you to all who stopped by and engaged with us
#EndoSky #MedSky #Ph3 #RZLT
📎 View the full poster here: bit.ly/416Pdt5
🙏Thank you to all who stopped by and engaged with us
#EndoSky #MedSky #Ph3 #RZLT
July 25, 2025 at 6:13 PM
📈ICYMI we presented Preliminary Patient Demographics And Baseline Characteristics from Phase 3 Study #sunRIZE of Ersodetug for Hypoglycemia due to #CongenitalHI at #ENDO2025
📎 View the full poster here: bit.ly/416Pdt5
🙏Thank you to all who stopped by and engaged with us
#EndoSky #MedSky #Ph3 #RZLT
📎 View the full poster here: bit.ly/416Pdt5
🙏Thank you to all who stopped by and engaged with us
#EndoSky #MedSky #Ph3 #RZLT
Proud to present "Preliminary Patient Demographics and Baseline Characteristics From a Phase 3 Study (sunRIZE) of Ersodetug for Hypoglycemia Due to Congenital Hyperinsulinism: Trial in Progress" today at #ENDO2025. View the full poster here: bit.ly/44x4GF6 #EndoSky #MedSky #CongenitalHi #RZLT
July 14, 2025 at 11:07 PM
Proud to present "Preliminary Patient Demographics and Baseline Characteristics From a Phase 3 Study (sunRIZE) of Ersodetug for Hypoglycemia Due to Congenital Hyperinsulinism: Trial in Progress" today at #ENDO2025. View the full poster here: bit.ly/44x4GF6 #EndoSky #MedSky #CongenitalHi #RZLT
If you’re at #ENDO2025 join Rezolute's team today 4:30-6:30pm at the #HypoglycemiaHappyHour on top of Moscone Center North. Learn about our #InsulinReceptorModulatingAntibody ersodetug, and the growing body of evidence to treat all forms of #hyperinsulinism #PostBariatricHI #TumorHI #CongenitalHI
July 13, 2025 at 6:35 PM
If you’re at #ENDO2025 join Rezolute's team today 4:30-6:30pm at the #HypoglycemiaHappyHour on top of Moscone Center North. Learn about our #InsulinReceptorModulatingAntibody ersodetug, and the growing body of evidence to treat all forms of #hyperinsulinism #PostBariatricHI #TumorHI #CongenitalHI
If attending the event, swing by to say hello on 7/14 at 12pm PT to learn more about this patient population and our progress in the space: bit.ly/3TqU1pf #ENDO2025 #ENDO #MedSky #PedSky #EndoSky #hypoglycemia #hyperinsulinism #congenitalHI #RZLT #Biotech
July 9, 2025 at 4:24 PM
If attending the event, swing by to say hello on 7/14 at 12pm PT to learn more about this patient population and our progress in the space: bit.ly/3TqU1pf #ENDO2025 #ENDO #MedSky #PedSky #EndoSky #hypoglycemia #hyperinsulinism #congenitalHI #RZLT #Biotech
We're thrilled to present “Preliminary Patient Demographics And Baseline Characteristics From A Phase 3 Study (sunRIZE) Of Ersodetug For Hypoglycemia Due To Congenital Hyperinsulinism: Trial In Progress" at #ENDO2025 in San Francisco! #ENDO #MedSky #PedSky #CongenitalHI #RZLT #biotech
July 9, 2025 at 4:22 PM